Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|March 2, 2013
Lack of regulatory changes of µ-opioid receptors by 14-methoxymetopon treatment in rat brain. Further evidence for functional selectivityResat Cinar, Orsolya Kékesi, Erika Birkás, et al.
Archiv Der Pharmazie|August 14, 2012
Synthesis and characterization of thiazolo- and thiazinomorphinans and their intermediate products as novel opioid-active derivativesAttila Sipos, Valeria Follia, Sándor Berényi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2006
Separation of binding affinity and intrinsic activity of the potent mu-opioid 14-methoxymetoponLoriann Mahurter, Carrie Garceau, Jacqueline Marino, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2016
Structural determinants of diphenethylamines for interaction with the κ opioid receptor: Synthesis, pharmacology and molecular modeling studiesElena Guerrieri, Marcel Bermudez, Gerhard Wolber, et al.
European Journal of Pharmacology|January 6, 2007
Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the ratIlona Obara, Wioletta Makuch, Mariana Spetea, et al.
Journal of Medicinal Chemistry|July 22, 2005
Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potencyMariana Spetea, Elisabeth Greiner, Mario D Aceto, et al.
Pageof 6